DM0000: The mark consists of the stylized wording "NATACYN" positioned above the wording (natamycin ophthalmic suspension) 5%.
GS0051: Pharmaceutical compositions for ophthalmological use containing natamycin; topical antifungal compositions for ophthalmological use containing natamycin
CC0000: Color is not claimed as a feature of the mark.
DS0000: natamycin
Case File Event Statements
2/12/2024 - a year ago
1 - NEW APPLICATION ENTEREDType:NWAP
6/18/2024 - 8 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
9/5/2024 - 5 months ago
3 - ASSIGNED TO EXAMINERType:DOCK
9/12/2024 - 5 months ago
5 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
9/12/2024 - 5 months ago
6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
9/12/2024 - 5 months ago
4 - EXAMINERS AMENDMENT -WRITTENType:CNEA
9/12/2024 - 5 months ago
7 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
9/17/2024 - 5 months ago
8 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
10/7/2024 - 4 months ago
12 - NON-FINAL ACTION E-MAILEDType:GNRT
10/1/2024 - 5 months ago
9 - WITHDRAWN FROM PUB - OG REVIEW QUERYType:PBCR
10/2/2024 - 5 months ago
10 - PREVIOUS ALLOWANCE COUNT WITHDRAWNType:ZZZX
10/7/2024 - 4 months ago
13 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
10/7/2024 - 4 months ago
11 - NON-FINAL ACTION WRITTENType:CNRT
1/7/2025 - a month ago
14 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
1/7/2025 - a month ago
15 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
1/8/2025 - a month ago
16 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
2/3/2025 - 28 days ago
17 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
2/19/2025 - 12 days ago
18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
2/25/2025 - 6 days ago
19 - PUBLISHED FOR OPPOSITIONType:PUBO
2/25/2025 - 6 days ago
20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB